Lidocaine Hydrochloride and Dextrose Injection Manufacturer

This subcontract involves the manufacture and supply of sterile, nonpyrogenic Lidocaine Hydrochloride and Dextrose Injection to support prime contractors fulfilling Department of Defense supply contracts through the Medical Supply Chain Pharm FSA. The production process requires compounding 2g of Lidocaine Hydrochloride USP and 5g of Hydrous Dextrose USP with Water for Injection USP to achieve a 500 ML bag fill volume. All manufacturing must occur in sterile compounding environments using containers that are latex-free, DEHP-free, and PVC-free to ensure full compliance with USP standards and FDA requirements. The performance of this contract is based in Williamsburg, Virginia, under NAICS code 325412. The scope of work concludes with the delivery of finished sterile injection bags. Interested parties should note the response deadline of November 3, 2026, for this specific procurement opportunity.